Abstract:Significance: Reactive oxygen species (ROS) are generated during mitochondrial oxidative metabolism, and are tightly controlled through homeostatic mechanisms to maintain intracellular redox, regulating growth and proliferation in healthy cells. However, ROS production is perturbed in cancers where abnormal accumulation of ROS leads to oxidative stress and genomic instability, triggering oncogenic signaling pathways on one hand, while increasing oxidative damage and triggering ROS-dependent death signaling on the other. Recent Advances: Our review illuminates how critical interactions between ROS and oncogenic signaling, the tumor microenvironment, and DNA damage response (DDR) pathways have led to interest in ROS modulation as a means of enhancing existing anticancer strategies and developing new therapeutic opportunities. Critical Issues: ROS equilibrium exists via a delicate balance of pro-oxidant and antioxidant species within cells. "Antioxidant" approaches have been explored mainly in the form of chemoprevention, but there is insufficient evidence to advocate its routine application. More progress has been made via the "pro-oxidant" approach of targeting cancer vulnerabilities and inducing oxidative stress. Various therapeutic modalities have employed this approach, including direct ROS-inducing agents, chemotherapy, targeted therapies, DDR therapies, radiotherapy, and immunotherapy. Finally, emerging delivery systems such as "nanosensitizers" as radiotherapy enhancers are currently in development. Future Directions: While approaches designed to induce ROS have shown considerable promise in selectively targeting cancer cells and dealing with resistance to conventional therapies, most are still in early phases of development and challenges remain. Further research should endeavor to refine treatment strategies, optimize drug combinations, and identify predictive biomarkers of ROS-based cancer therapies.

Reactive Oxygen Species, Metabolic Plasticity, and Drug Resistance in Cancer

The Role of Aberrant Metabolism in Cancer: Insights into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer

Targeting Metabolic-Redox Circuits for Cancer Therapy

Metabolic Regulation of Redox Balance in Cancer

Targeting the Redox Landscape in Cancer Therapy

Altered metabolism in cancer: insights into energy pathways and therapeutic targets

Redox Dysregulation in the Tumor Microenvironment Contributes to Cancer Metastasis.

Oxidative Stress in Cancer Cell Metabolism

[A Review of the Redox Regulation of Tumor Metabolism].

Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response

The Effect of Oxidative Phosphorylation on Cancer Drug Resistance

Generation and Application of Reactive Oxygen Radicals in Cancer Treatment

Reactive Oxygen Species: A Key Constituent in Cancer Survival

Cancer Metabolism and Intervention Therapy

Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements

Targeting mitochondrial metabolism for metastatic cancer therapy

Reactive oxygen species and cancer paradox: To promote or to suppress?

Oxidative Stress and Drug Resistance in Cancer

Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies

Targeting cellular metabolism to improve cancer therapeutics

Energy metabolism in cancer stem cells